Government looks to review Tocilizumab inclusion for treatment, again
Tocilizumab,a rheumatoid arthritis drug, is part of the health ministry’s clinical management protocol for Covid-19 under investigational therapies for patients with moderate symptoms of the illness.
Source: The Economic Times - Category: Consumer Health News Source Type: news
More News: Actemra | Arthritis | COVID-19 | Government | Health | Rheumatoid Arthritis | Rheumatology